BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 35624831)

  • 1. Oxidative Stress in Chronic Obstructive Pulmonary Disease.
    Barnes PJ
    Antioxidants (Basel); 2022 May; 11(5):. PubMed ID: 35624831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress-based therapeutics in COPD.
    Barnes PJ
    Redox Biol; 2020 Jun; 33():101544. PubMed ID: 32336666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1.
    Malhotra D; Thimmulappa R; Navas-Acien A; Sandford A; Elliott M; Singh A; Chen L; Zhuang X; Hogg J; Pare P; Tuder RM; Biswal S
    Am J Respir Crit Care Med; 2008 Sep; 178(6):592-604. PubMed ID: 18556627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent evidence from omic analysis for redox signalling and mitochondrial oxidative stress in COPD.
    Mumby S; Adcock IM
    J Inflamm (Lond); 2022 Jul; 19(1):10. PubMed ID: 35820851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease.
    Biswas S; Hwang JW; Kirkham PA; Rahman I
    Curr Med Chem; 2013; 20(12):1496-530. PubMed ID: 22963552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Potential of Small Molecules Targeting Oxidative Stress in the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Comprehensive Review.
    Dailah HG
    Molecules; 2022 Aug; 27(17):. PubMed ID: 36080309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease.
    Wiegman CH; Michaeloudes C; Haji G; Narang P; Clarke CJ; Russell KE; Bao W; Pavlidis S; Barnes PJ; Kanerva J; Bittner A; Rao N; Murphy MP; Kirkham PA; Chung KF; Adcock IM;
    J Allergy Clin Immunol; 2015 Sep; 136(3):769-80. PubMed ID: 25828268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: antioxidant therapeutic targets.
    Rahman I
    Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):291-315. PubMed ID: 14561194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease.
    Lin JL; Thomas PS
    COPD; 2010 Aug; 7(4):291-306. PubMed ID: 20673039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative and Nitrosative Stress in the Pathogenesis of Obstructive Lung Diseases of Increasing Severity.
    Di Stefano A; Maniscalco M; Balbi B; Ricciardolo FLM
    Curr Med Chem; 2020; 27(42):7149-7158. PubMed ID: 32496983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidants/antioxidants and chronic obstructive pulmonary disease: pathogenesis to therapy.
    MacNee W
    Novartis Found Symp; 2001; 234():169-85; discussion 185-8. PubMed ID: 11199095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of oxidative stress in the pathogenesis of COPD: implications for therapy.
    Rahman I
    Treat Respir Med; 2005; 4(3):175-200. PubMed ID: 15987234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The plant flavonoid, fisetin alleviates cigarette smoke-induced oxidative stress, and inflammation in Wistar rat lungs.
    Hussain T; Al-Attas OS; Alamery S; Ahmed M; Odeibat HAM; Alrokayan S
    J Food Biochem; 2019 Aug; 43(8):e12962. PubMed ID: 31368542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria-Targeted Antioxidants as a Therapeutic Strategy for Chronic Obstructive Pulmonary Disease.
    Fairley LH; Das S; Dharwal V; Amorim N; Hegarty KJ; Wadhwa R; Mounika G; Hansbro PM
    Antioxidants (Basel); 2023 Apr; 12(4):. PubMed ID: 37107348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neu-164 and Neu-107, two novel antioxidant and anti-myeloperoxidase compounds, inhibit acute cigarette smoke-induced lung inflammation.
    Thatcher TH; Hsiao HM; Pinner E; Laudon M; Pollock SJ; Sime PJ; Phipps RP
    Am J Physiol Lung Cell Mol Physiol; 2013 Jul; 305(2):L165-74. PubMed ID: 23686858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidants/antioxidants and COPD.
    MacNee W
    Chest; 2000 May; 117(5 Suppl 1):303S-17S. PubMed ID: 10843965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress in COPD and its measurement through exhaled breath condensate.
    Lee W; Thomas PS
    Clin Transl Sci; 2009 Apr; 2(2):150-5. PubMed ID: 20443881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease.
    Boutten A; Goven D; Artaud-Macari E; Boczkowski J; Bonay M
    Trends Mol Med; 2011 Jul; 17(7):363-71. PubMed ID: 21459041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress in COPD.
    Kirkham PA; Barnes PJ
    Chest; 2013 Jul; 144(1):266-273. PubMed ID: 23880677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant therapeutic advances in COPD.
    Rahman I
    Ther Adv Respir Dis; 2008 Dec; 2(6):351-74. PubMed ID: 19124382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.